Sparks commentary - Cereno Scientific

Healthcare

Sparks - Cereno Scientific

More on this equity
Cereno Scientific (STO: CRNO-B) enters the FN25 Index
Published by Jyoti Prakash, CFA

Cereno Scientific has announced the company’s inclusion into the Nasdaq First North 25 Index, which consists of the 25 largest and most traded shares listed on the Nasdaq Nordic First North Growth Markets (First North Denmark, First North Finland, First North Iceland and First North Sweden). This has been driven by the strong trading performance by the company in recent months (share price has nearly doubled since April 2025 to SEK10.15), indicating shareholder optimism in its rare disease-focused developmental pipeline. We value Cereno at SEK16.0 per share.

Latest

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free